BIOREPOSITORY CENTER

生物样本库中心

• 批准号: 8436441
• 负责人: William L. Carroll
• 金额: $ 13.74万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-03-01 至 2018-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8436441
• 关键词: Anatomy; Biological Models; Cancer Center Support Grant; Clinical; Collaborations; Diagnosis; Disease Progression; Doctor of Philosophy; Ensure; Genetic; Goals; Guidelines; Health Insurance Portability and Accountability Act; Human; Informed Consent; Institutes; Institutional Review Boards; Instruction; Investigation; Link; Malignant Neoplasms; Non-Malignant; Operative Surgical Procedures; Pathologic Processes; Pathologist; Pathology; Patient Care; Patient Rights; Play; Preparation; Privacy; Protocols documentation; Research; Research Personnel; Role; Scientist; Services; Surgeon; Tissue Banks; Tissue Sample; Tissues; Translational Research; Work; biobank; design; human disease; human tissue; member; novel therapeutics; prospective; repository; sample collection

PROJECT SUMMARY (See instructions): The overarching goal of the BioRepository Center (BRC) is to facilitate translational research. Tight coordination between surgical staff, pathologists, and BRC enables collection of specimens to fulfill investigators' needs. Our protocols for rapid acquisition of tissue samples allows for preparation of high quality analytes. Patients' rights and privacy by our participation in obtaining and confirming informed consent for tissue collection; guidance with regard to preparation and submission of IRB documents is offered to help ensure compliance. The BRC also promotes collaborations between clinical and basic scientists, and can aid in the design and execution of prospective, hypothesis-driven studies to examine the impact of genetics or treatment on disease progression. By promoting investigators access to appropriate biospecimens, the BRC enhances the ability of NYULMC Cancer Institute members to perform meaningful translational research.

项目总结（见说明）： BioRepository Center（BRC）的首要目标是促进转化研究。外科工作人员、病理学家和BRC之间的紧密协调使标本采集能够满足研究者的需求。我们的快速采集组织样本的方案允许制备高质量的分析物。通过我们参与获取和确认组织采集的知情同意书，保护患者的权利和隐私;提供关于IRB文件准备和提交的指导，以帮助确保合规性。BRC还促进临床和基础科学家之间的合作，并可以帮助设计和执行前瞻性，假设驱动的研究，以检查遗传学或治疗对疾病进展的影响。通过促进研究人员获得适当的生物标本，BRC提高了NYULMC癌症研究所成员进行有意义的转化研究的能力。